Loading Events

AAPS 2024 PharmSci 360

Share this event:

The event has passed.

Start Date

October 20 @ 8:30 am

End Date

October 23 @ 1:30 pm

City

Salt Lake City

Join us at AAPS 2024.
Booth #1610

PharmSci 2024 brings together leading researchers from academia and industry. You will hear about the latest in cutting edge science.

Our Science

Presentations

Aihua Lia, PhD | Executive Director
Tuesday 22 Oct | 3:15 pm
Advanced LCMS Strategies for Both Antibody and Payload Bioanalysis

 

Bao Lam, PhD | Scientist
Wednesday 23 Oct | 3:00 pm
Problematic Aggregation of Biotinylated and Sulfo-Tagged Proteins in Immunoassays

 

Posters

David Zuluaga-Rave, MS
Tuesday 22 Oct | 09:30 – 10:30 (T0930-06-35)
Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K2EDTA Plasma Using SEC-MS

 

Eric Munoz, BS
Wednesday 23 Oct | 10:30 – 11:30am (W1030-06-32)
An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug

Venue Details

Salt Palace Convention Center, 90 South West Temple,
Salt Lake City, UT 84101 United States

Events Details

Time :
8:30 am - 1:30 pm
Categories :

Add to Calendar

More Events

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.